menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Pantherx Rare: Upsher-Smith Picks It For Vigafyde Oral Solution

    PR NEWSWIRE

    Ovid Therapeutics Presents Pre-Clinical Results On OV329

    GLOBENEWSWIRE

    Pyros Pharmaceuticals Launches VIGAFYDE, Ready-to-Use Vigabatrin Solution

    BUSINESSWIRE

    Pyros Pharma`s Vigafyde (vigabatrin) Receives Approval in the U.S

    FDA

    Pyros Pharmaceuticals Announces FDA Approval of VIGAFYDE™

    BIOSPACE

    Pyros Pharms New Vigabatrin Receives Approval in US

    FDA

    Pyros Pharma Announces FDA Approval Of VIGAFYDE™ Oral Solution

    BUSINESSWIRE

    Upsher-Smith Rare Disease Portfolio At AAN 2024

    PR NEWSWIRE

    Pyros Pharmaceuticals Announces VIGPODER™ (vigabatrin) is Now Available

    BUSINESSWIRE

    Pyros Announces Positive Outcome of the Procedure for Approval of VIGZIP

    BUSINESSWIRE

    InvaGen Pharmaceuticals Issues Voluntary Nationwide Recall of Vigabatrin for Oral Solution, USP 500mg due to Leaking Sachets

    FDA

    InvaGen issues Voluntary Nationwide Recall of Vigabatrin for Oral Solution

    PR NEWSWIRE

    InvaGen Issues Voluntary Nationwide Recall of Vigabatrin for Oral Solution

    PR NEWSWIRE

    Health Canada Issues Recall of Sabril (vigabatrin) 500 mg sachets found to contain trace amounts of another drug

    HEALTH CANADA

    Enforcement Report - Week of September 6, 2023

    FDA

    Enforcement Report - Week of March 8, 2023

    FDA

    MSN`s Generic Vigabatrin Receives Approval in the U.S.

    FDA

    Hikma`s Generic Vigabatrin Receives Approval in the U.S.

    FDA

    Amneal Pharma`s Generic Erlotinib Hydrochloride Receives Approval in US

    FDA

    Lupin gets USFDA nod to market generic drug

    ECONOMIC TIMES

    Lupin`s Generic Vigabatrin Receives Approval in the U.S.

    FDA

    Zydus gets final US FDA nod to market generic version of Vigabatrin tablets

    ECONOMIC TIMES

    Zydus` Generic Vigabatrin Receives Approval in the U.S.

    FDA

    Par Pharma`s Generic Isosorbide Dinitrate Receives Approval in the US

    FDA

    Aurobindo Pharma`s Generic Vigabatrin Receives Approval In US

    FDA

    Dexcel Pharma`s Generic Vigabatrin Receives Approval in the US

    FDA

    Specgx LLC Generic Vigabatrin Receives Approval In US

    FDA

    Dr. Reddy`s Laboratories Announces the Launch of Vigabatrin Tablets, USP

    BUSINESSWIRE

    Annora Pharma`s Generic Vigabatrin Receives Approval In US

    FDA

    Alkem Labs`s Generic Vigabatrin Receives Approval In US

    FDA

    InvaGen Pharmaceuticals`s Generic Vigabatrin Receives Approval in US

    FDA

    Dr Reddy`s launches generic oral anti-epileptic drug in US

    ECONOMICTIMES

    Dr. Reddy`s Launches Vigabatrin in the US

    BIOSPECTRUMASIA

    Dr Reddy’s gains on launch of Vigabatrin powder

    MONEYCONTROL

    Lundbeck’s key products shine in Q2 but problems remain

    PMLIVE

    Aucta partners with Fosun Pharma to market the FDA-approved Vigabatrin

    GLOBENEWSWIRE

    Aucta Pharmaceuticals Announces Licensing of Vigabatrin for Oral Solution in China

    WORLDPHARMATODAY

    Aucta Receives its First Approval & Launches Vigabatrin for Brand Name Vigadrone™

    GLOBENEWSWIRE

    Copycats wanted: Pfizer, AZ and more under threat as China solicits generics

    FIERCE PHARMA

    Teva announces US launch of Vigabatrin

    BIOSPECTRUM

    FDA approves first generic version of Sabril

    FDA

    VIGABATRIN - Product Details for ANDA 209822

    FDA

    FDA approves first generic version of Sabril to treat seizures

    FDA

    FDA Approves First Generic Version of Lundbeck’s Sabril

    RAPS

    Teva Pharms USA`s Generic Vigabatrin Receives Approval in US

    FDA

    Dr Reddys Labs ` Generic Vigabatrin Receives Approval in US

    FDA

    ORPHELIA Pharma`s Kigabeq (vigabatrin) receives approval in Europe

    EMA

    Catalent to formulate vigabatrin into novel dosage form through agreement

    EPMMAGAZINE

    CHMP recommends paediatric-use marketing authorisation for Kigabeq and Slenyto

    PHARMABIZ

    Meeting highlights from the CHMP 23-26 July 2018

    EMA

    Two new paediatric-use marketing authorisations recommended by CHMP

    EMA

    Aucta Receives its First Product Approval and Launches Vigabatrin for Oral Solution Under the Brand Name Vigadrone™

    PRESS RELEASE

    Aucta Pharma`s Generic Vigabatrin Receives Approval in US

    FDA

    Amneal Launches Generic for Sabril®: Vigabatrin for Oral Solution, USP

    PR NEWSWIRE

    Teva Pharms USA Generic Vigabatrin Receives Approval In US

    FDA

    Aucta Receives its First Product Approval and Launches Vigabatrin

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.